Oral Sessions最新文献

筛选
英文 中文
1306 Molecular subgroups versus risk of sentinel lymph node metastases and recurrence in endometrial cancer 1306 子宫内膜癌分子亚群与前哨淋巴结转移和复发风险的关系
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.37
M. Lombaers, Stéphanie W Vrede, Tommaso Occhiali, Emma ZM Heebink, G. Cucinella, Puck Van Gestel, J. Bulten, Remco Van Cruchten, Paul DM Rombout, Annemiek Kastner- Van Raaij, Maryam Shahi, Andrea Mariani, J. Pijnenborg
{"title":"1306 Molecular subgroups versus risk of sentinel lymph node metastases and recurrence in endometrial cancer","authors":"M. Lombaers, Stéphanie W Vrede, Tommaso Occhiali, Emma ZM Heebink, G. Cucinella, Puck Van Gestel, J. Bulten, Remco Van Cruchten, Paul DM Rombout, Annemiek Kastner- Van Raaij, Maryam Shahi, Andrea Mariani, J. Pijnenborg","doi":"10.1136/ijgc-2024-esgo.37","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.37","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"225 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140402970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
86 Quality assurance for surgery and pathology for patients randomized before 2022 in SENTICOL III (international validation study of sentinel node biopsy in early cervical cancer) 86 SENTICOL III(早期宫颈癌前哨节点活检的国际验证研究)2022 年前随机患者的手术和病理质量保证
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.1
Fabrice Lecuru, Gwenael Ferron, G. Baiocchi, Julie Henriques, Tao Zhu, G. Martino, Akira Yabuno, Ane Gerda Zahl Eriksson, Milan Krkoska, François Golfier, G. Guitmann, V. Fourchotte, Jeremie Belghiti, Amelie Charnevriat, Fabrice Narducci, Martin Koskas, Estelle Wafo, Anca Birsan, E. Lambaudie, Marie Plante
{"title":"86 Quality assurance for surgery and pathology for patients randomized before 2022 in SENTICOL III (international validation study of sentinel node biopsy in early cervical cancer)","authors":"Fabrice Lecuru, Gwenael Ferron, G. Baiocchi, Julie Henriques, Tao Zhu, G. Martino, Akira Yabuno, Ane Gerda Zahl Eriksson, Milan Krkoska, François Golfier, G. Guitmann, V. Fourchotte, Jeremie Belghiti, Amelie Charnevriat, Fabrice Narducci, Martin Koskas, Estelle Wafo, Anca Birsan, E. Lambaudie, Marie Plante","doi":"10.1136/ijgc-2024-esgo.1","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.1","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140404513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study 187 TP53wt晚期或复发性子宫内膜癌患者的Selinexor维持治疗:ENGOT-EN5/GOG-3055/SIENDO研究疗效和安全性亚组分析的长期随访
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.20
J. Sehouli, I. Vergote, Erika Hamilton, Alejandro Pérez Fidalgo, T. Gorp, G. Scambia, Jaroslav Klát, Tally Levy, S. Welch, Debra L Richardson, Eva Maria Guerra Alía, Stéphanie Henry, P. Wimberger, David S Miller, Jerónimo Martínez, Bradley J. Monk, Pratheek Kalyanapu, M.R. Mirza, Vicky Makker
{"title":"187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study","authors":"J. Sehouli, I. Vergote, Erika Hamilton, Alejandro Pérez Fidalgo, T. Gorp, G. Scambia, Jaroslav Klát, Tally Levy, S. Welch, Debra L Richardson, Eva Maria Guerra Alía, Stéphanie Henry, P. Wimberger, David S Miller, Jerónimo Martínez, Bradley J. Monk, Pratheek Kalyanapu, M.R. Mirza, Vicky Makker","doi":"10.1136/ijgc-2024-esgo.20","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.20","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"8 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140406603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
161 Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: the randomized, double-blind, phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 study 161 Pembrolizumab 联合化放疗治疗高风险局部晚期宫颈癌:随机、双盲、3 期 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 研究
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.3
Domenica Lorusso, Y. Xiang, Kosei Hasegawa, G. Scambia, Manuel Leiva, Pier Ramos-Elias, A. Acevedo, J. Vizkeleti, A.J.P.D.S. Gomes, Fernando Contreras Mejia, A. Reiss, Ali Ayhan, Jung-Yun Lee, V. Saevets, F. Zagouri, Kan Li, Karin Yamada, Sarper Toker, Sandro Pignata, L. Duska
{"title":"161 Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: the randomized, double-blind, phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 study","authors":"Domenica Lorusso, Y. Xiang, Kosei Hasegawa, G. Scambia, Manuel Leiva, Pier Ramos-Elias, A. Acevedo, J. Vizkeleti, A.J.P.D.S. Gomes, Fernando Contreras Mejia, A. Reiss, Ali Ayhan, Jung-Yun Lee, V. Saevets, F. Zagouri, Kan Li, Karin Yamada, Sarper Toker, Sandro Pignata, L. Duska","doi":"10.1136/ijgc-2024-esgo.3","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.3","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"19 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140399881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
462 Progression-free survival 2-progression-free survival 1 in patients with primary advanced/recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial 462 在ENGOT-EN6-NSGO/GOG-3031/RUBY试验中,与单纯化疗相比,多司他单抗联合化疗治疗原发性晚期/复发性子宫内膜癌患者的无进展生存期2-无进展生存期1
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.25
C. Mccourt, G. Ronzino, M. Shahin, Rebecca Kristeleit, L. Willmott, Oleksandr Zub, J. Barlin, L. Gilbert, N. Cloven, Line Bjørge, D. Black, M. Wymenga, Sudarshan Sharma, Michael A Gold, Lisa Landrum, C. Mathews, Grace Antony, S. Stevens, M. Powell, M. Mirza
{"title":"462 Progression-free survival 2-progression-free survival 1 in patients with primary advanced/recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","authors":"C. Mccourt, G. Ronzino, M. Shahin, Rebecca Kristeleit, L. Willmott, Oleksandr Zub, J. Barlin, L. Gilbert, N. Cloven, Line Bjørge, D. Black, M. Wymenga, Sudarshan Sharma, Michael A Gold, Lisa Landrum, C. Mathews, Grace Antony, S. Stevens, M. Powell, M. Mirza","doi":"10.1136/ijgc-2024-esgo.25","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.25","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"62 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140403888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
342 Evaluation of the effectiveness and safety of disitamab vedotin for HER2-expressing recurrent cervical cancer after progression on platinum-based treatment-a single-arm, multicenter, open-label, phase II clinical study 342 评价地西他单抗维多汀治疗铂类药物治疗进展后HER2表达复发性宫颈癌的有效性和安全性--一项单臂、多中心、开放标签的II期临床研究
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.10
Lingying Wu, Guiling Li, Youzhong Zhang, Ruifang An, Li Sun, Keqiang Zhang, Yi Huang, Ruixia Guo, Qingshui Li, Jinwei Miao, A. Lin, Jianlin Yuan, G. Lou, Hongying Yang, Yu Zhang, Hui Zhang, Aiqin He, Junying Tang, Jianming Ying, Yun Ling, Jianmin Fang
{"title":"342 Evaluation of the effectiveness and safety of disitamab vedotin for HER2-expressing recurrent cervical cancer after progression on platinum-based treatment-a single-arm, multicenter, open-label, phase II clinical study","authors":"Lingying Wu, Guiling Li, Youzhong Zhang, Ruifang An, Li Sun, Keqiang Zhang, Yi Huang, Ruixia Guo, Qingshui Li, Jinwei Miao, A. Lin, Jianlin Yuan, G. Lou, Hongying Yang, Yu Zhang, Hui Zhang, Aiqin He, Junying Tang, Jianming Ying, Yun Ling, Jianmin Fang","doi":"10.1136/ijgc-2024-esgo.10","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.10","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"477 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
270 Survival outcomes following cytoreductive surgery in advanced ovarian cancer patients: prognosis is better predicted by completeness of resection than by disease stage 270 晚期卵巢癌患者接受细胞切除手术后的生存预后:切除完整性比疾病分期更能预测预后
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.42
O. Elyashiv, Radha Graham, Nicholas Counsell, Nick Jayanth, Lauren Berg, Keeley Howard, Joseph T Gleeson, Konstantinos Doufekas, Nicola D Macdonald, Jonathan Ledermann, Ioannis C Kotsopoulos
{"title":"270 Survival outcomes following cytoreductive surgery in advanced ovarian cancer patients: prognosis is better predicted by completeness of resection than by disease stage","authors":"O. Elyashiv, Radha Graham, Nicholas Counsell, Nick Jayanth, Lauren Berg, Keeley Howard, Joseph T Gleeson, Konstantinos Doufekas, Nicola D Macdonald, Jonathan Ledermann, Ioannis C Kotsopoulos","doi":"10.1136/ijgc-2024-esgo.42","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.42","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"90 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
648 Tumour size assessment in patients with early-stage cervical cancer and its impact on a tailored management: final results of a prospective, international multicenter study SENTIX (CEEGOG CX-01; ENGOT-CX2) 648 早期宫颈癌患者的肿瘤大小评估及其对针对性治疗的影响:前瞻性国际多中心研究 SENTIX(CEEGOG CX-01;ENGOT-CX2)的最终结果
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.17
Roman Kocián, Christhardt Köhler, I. Zapardiel, K. Němejcová, Jaroslav Klát, Vladimír Kalist, W. Szatkowski, D. Wydra, Karl Tamussino, Róbert Tóth, Marcin Misiek, M. Redecha, Isabel Martin, F. Kridelka, Jirí Jarkovský, Alla Vinnytska, Francisco Javier De Santiago García, M. Borčinová, Grzegorz Szewczyk, David Cibula
{"title":"648 Tumour size assessment in patients with early-stage cervical cancer and its impact on a tailored management: final results of a prospective, international multicenter study SENTIX (CEEGOG CX-01; ENGOT-CX2)","authors":"Roman Kocián, Christhardt Köhler, I. Zapardiel, K. Němejcová, Jaroslav Klát, Vladimír Kalist, W. Szatkowski, D. Wydra, Karl Tamussino, Róbert Tóth, Marcin Misiek, M. Redecha, Isabel Martin, F. Kridelka, Jirí Jarkovský, Alla Vinnytska, Francisco Javier De Santiago García, M. Borčinová, Grzegorz Szewczyk, David Cibula","doi":"10.1136/ijgc-2024-esgo.17","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.17","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"7 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140406638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
407 COPELIA: a 3-arm randomised phase II trial of weekly paclitaxel with or without cediranib or olaparib with cediranib in recurrent endometrial cancer 407 COPELIA:复发性子宫内膜癌每周紫杉醇联合或不联合西地尼布或奥拉帕利联合西地尼布的三臂随机II期试验
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.24
A. Clamp, Catharine Porter, Ann White, Alys Irving, Angela Casbard, Marcia Hall, G. Eminowicz, Angela George, Axel Walther, Adrian Franklin, Azmat Sadozye, Louise Hanna, Andrew Hughes, Rene Roux, Rosemary Lord, Rebecca Bowen, Joey Wood, Clara Sentamans, Rebecca Kristeleit, G. Jayson
{"title":"407 COPELIA: a 3-arm randomised phase II trial of weekly paclitaxel with or without cediranib or olaparib with cediranib in recurrent endometrial cancer","authors":"A. Clamp, Catharine Porter, Ann White, Alys Irving, Angela Casbard, Marcia Hall, G. Eminowicz, Angela George, Axel Walther, Adrian Franklin, Azmat Sadozye, Louise Hanna, Andrew Hughes, Rene Roux, Rosemary Lord, Rebecca Bowen, Joey Wood, Clara Sentamans, Rebecca Kristeleit, G. Jayson","doi":"10.1136/ijgc-2024-esgo.24","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.24","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"256 15","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
285 Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-Cx11/GOG 3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in patients with high-risk locally advanced cervical cancer 285 在高风险局部晚期宫颈癌患者中开展的 3 期随机、双盲、安慰剂对照 ENGOT-Cx11/GOG 3047/KEYNOTE-A18 研究的患者报告结果
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.53
Sandro Pignata, Vladyslav Sukhin, N. Colombo, J. Korach, Takashi Matsumoto, Susan Lalondrelle, J. Vizkeleti, Leslie M Randall, Vanessa Samouelian, Pamela Salman, Angélica Nogueira-Rodrigues, Ali Ayhan, Juan F Cueva, Yong Man Kim, E. Petru, Karin Yamada, Kan Li, Elizabeth Szamreta, Allison Martin Nguyen, Domenica Lorusso
{"title":"285 Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-Cx11/GOG 3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in patients with high-risk locally advanced cervical cancer","authors":"Sandro Pignata, Vladyslav Sukhin, N. Colombo, J. Korach, Takashi Matsumoto, Susan Lalondrelle, J. Vizkeleti, Leslie M Randall, Vanessa Samouelian, Pamela Salman, Angélica Nogueira-Rodrigues, Ali Ayhan, Juan F Cueva, Yong Man Kim, E. Petru, Karin Yamada, Kan Li, Elizabeth Szamreta, Allison Martin Nguyen, Domenica Lorusso","doi":"10.1136/ijgc-2024-esgo.53","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.53","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140401837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信